FDA clears Novocure's wearable Optune Pax therapy for pancreatic cancer #$NVCR firstwordpharma.com/story/7103267
February 13, 2026 at 12:07 AM
FDA clears Novocure's wearable Optune Pax therapy for pancreatic cancer #$NVCR firstwordpharma.com/story/7103267
$NVCR jumps after FDA OKs Optune Pax for advanced pancreatic cancer, first new treatment in decades. Phase 3 showed improved survival.
www.biopharmcatalyst.com/news/2026/no...
www.biopharmcatalyst.com/news/2026/no...
Pre-Market Updates 02/12/26
export-download.canva.com
February 12, 2026 at 1:40 PM
$NVCR jumps after FDA OKs Optune Pax for advanced pancreatic cancer, first new treatment in decades. Phase 3 showed improved survival.
www.biopharmcatalyst.com/news/2026/no...
www.biopharmcatalyst.com/news/2026/no...
#Trading #Stockmarket
Stock Premarket - Feb 12, 2026
See StockQuakes.substack.com
UP
↑ JDZG Jiade LTD 43.2%
↑ NVCR Novocure LTD 29.4%
↑ VKTX Viking Therapeutics, Inc. 15.5%
↑ SSII Ss Innovations Internation... 14.5%
↑ JZXN Jiuzi Holdings, Inc. 12.0%
↑ GNLN Greenlane Holdings, Inc. 11.9%
Stock Premarket - Feb 12, 2026
See StockQuakes.substack.com
UP
↑ JDZG Jiade LTD 43.2%
↑ NVCR Novocure LTD 29.4%
↑ VKTX Viking Therapeutics, Inc. 15.5%
↑ SSII Ss Innovations Internation... 14.5%
↑ JZXN Jiuzi Holdings, Inc. 12.0%
↑ GNLN Greenlane Holdings, Inc. 11.9%
StockQuakes | StockQuakes Team | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.
StockQuakes.substack.com
February 12, 2026 at 1:33 PM
#Trading #Stockmarket
Stock Premarket - Feb 12, 2026
See StockQuakes.substack.com
UP
↑ JDZG Jiade LTD 43.2%
↑ NVCR Novocure LTD 29.4%
↑ VKTX Viking Therapeutics, Inc. 15.5%
↑ SSII Ss Innovations Internation... 14.5%
↑ JZXN Jiuzi Holdings, Inc. 12.0%
↑ GNLN Greenlane Holdings, Inc. 11.9%
Stock Premarket - Feb 12, 2026
See StockQuakes.substack.com
UP
↑ JDZG Jiade LTD 43.2%
↑ NVCR Novocure LTD 29.4%
↑ VKTX Viking Therapeutics, Inc. 15.5%
↑ SSII Ss Innovations Internation... 14.5%
↑ JZXN Jiuzi Holdings, Inc. 12.0%
↑ GNLN Greenlane Holdings, Inc. 11.9%
#$NVCR +22% [Novocure's Optune Pax wearable device wins FDA approval for locally advanced pancreatic cancer with gemcitabine + nab-paclitaxel. Phase 3 trial shows improved survival and delayed pain progression.] notreload.xyz/fda-approves...
FDA Approves Optune Pax for Pancreatic Cancer Treatment
Novocure's Optune Pax wearable device wins FDA approval for locally advanced pancreatic cancer with gemcitabine + nab-paclitaxel. Phase 3 trial shows improved survival and delayed pain progression.
notreload.xyz
February 12, 2026 at 11:10 AM
#$NVCR +22% [Novocure's Optune Pax wearable device wins FDA approval for locally advanced pancreatic cancer with gemcitabine + nab-paclitaxel. Phase 3 trial shows improved survival and delayed pain progression.] notreload.xyz/fda-approves...
Buy $NVCR (NVCR.O) @ 22:27:38
February 11, 2026 at 10:27 PM
Buy $NVCR (NVCR.O) @ 22:27:38
Small-cap stocks with strong volume declines, Thu Feb 5th - #$WLAC #$RSSS #$GSUN #$AREB #$VCIC #$TBHC #$NVCR #$GEOS #$CRNC #$BGM #$AMSC #$SLQT #$LSPD #$GOOS #$FMC #$DDL - More: crystalequityresearch.com/leading-indi... - #smallcap
Leading Indicators, Thursday February 5, 2026 – Crystal Equity Research
crystalequityresearch.com
February 5, 2026 at 10:06 PM
as someone curious about israeli scam company #$NVCR i find it intriguing that there are epstein/israeli intelligence connections to other american neurologists
January 31, 2026 at 4:11 PM
as someone curious about israeli scam company #$NVCR i find it intriguing that there are epstein/israeli intelligence connections to other american neurologists
Manually setting page numbers in Affinity will delay NVCR by at least 2 weeks. Anyone got an idea on how to do this shit automatically?
January 17, 2026 at 3:47 PM
Manually setting page numbers in Affinity will delay NVCR by at least 2 weeks. Anyone got an idea on how to do this shit automatically?
Novocure Beats Q4 Revenue Targets, But Slowing Core Product Raises Growth Questions https://signalbloom.ai/news/NVCR/novocure-beats-q4-revenue-targets-but-slowing-core-product-raises-growth-questions $NVCR #Earnings via @signalbloom.ai
January 12, 2026 at 2:04 PM
Novocure Beats Q4 Revenue Targets, But Slowing Core Product Raises Growth Questions https://signalbloom.ai/news/NVCR/novocure-beats-q4-revenue-targets-but-slowing-core-product-raises-growth-questions $NVCR #Earnings via @signalbloom.ai
Small-cap stocks in new uptrend according to average directional index, Mon Jan 5th - #MYO #TIGR #SKYT #PEPG #NVCR #MRAM #GHRS #CSWC #AZ #WEAV #EVTL #CRI #ACVA - More: crystalequityresearch.com/leading-indi... - #smallcap
Leading Indicators, Monday January 5, 2026 – Crystal Equity Research
crystalequityresearch.com
January 5, 2026 at 11:10 PM
Today's work complete.
Two chapters rewritten, 6 new items added, 2 mech sets fleshed out.
After proofreading and maybe more worldbuilding, it is possible i could release NVCR in early 2026. Probably not, but it's nice to have hope.
Two chapters rewritten, 6 new items added, 2 mech sets fleshed out.
After proofreading and maybe more worldbuilding, it is possible i could release NVCR in early 2026. Probably not, but it's nice to have hope.
December 28, 2025 at 4:39 PM
Today's work complete.
Two chapters rewritten, 6 new items added, 2 mech sets fleshed out.
After proofreading and maybe more worldbuilding, it is possible i could release NVCR in early 2026. Probably not, but it's nice to have hope.
Two chapters rewritten, 6 new items added, 2 mech sets fleshed out.
After proofreading and maybe more worldbuilding, it is possible i could release NVCR in early 2026. Probably not, but it's nice to have hope.
And this one. I was there…
youtu.be/NVcr-yVRiT0?...
youtu.be/NVcr-yVRiT0?...
Most people i know Sunbury 1972
YouTube video by TheRoyandrews
youtu.be
December 7, 2025 at 5:29 AM
And this one. I was there…
youtu.be/NVcr-yVRiT0?...
youtu.be/NVcr-yVRiT0?...
Wall Street Weekly Wrap Up November 1 2025
This week we discuss BE, UNH, NVDA, GOOG, META, MSFT, AMZN, NEE, LLY, UDR, XOM, RDDT, AAPL, AI Chips, UPS, Bitcoin, XLV, INKY, NVCR, Heat Map
NExtGen Portfolio up 21.95%
youtu.be/dzASsBwUGZ0
This week we discuss BE, UNH, NVDA, GOOG, META, MSFT, AMZN, NEE, LLY, UDR, XOM, RDDT, AAPL, AI Chips, UPS, Bitcoin, XLV, INKY, NVCR, Heat Map
NExtGen Portfolio up 21.95%
youtu.be/dzASsBwUGZ0
youtu.be
November 1, 2025 at 12:02 PM
Wall Street Weekly Wrap Up November 1 2025
This week we discuss BE, UNH, NVDA, GOOG, META, MSFT, AMZN, NEE, LLY, UDR, XOM, RDDT, AAPL, AI Chips, UPS, Bitcoin, XLV, INKY, NVCR, Heat Map
NExtGen Portfolio up 21.95%
youtu.be/dzASsBwUGZ0
This week we discuss BE, UNH, NVDA, GOOG, META, MSFT, AMZN, NEE, LLY, UDR, XOM, RDDT, AAPL, AI Chips, UPS, Bitcoin, XLV, INKY, NVCR, Heat Map
NExtGen Portfolio up 21.95%
youtu.be/dzASsBwUGZ0
NovoCure ($NVCR) reported EPS of -0.33 beating estimate of -0.42 for Q3 2025. Revenue 167.204 Million Vs 158.3385 Million expected.
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
October 30, 2025 at 9:11 PM
NovoCure ($NVCR) reported EPS of -0.33 beating estimate of -0.42 for Q3 2025. Revenue 167.204 Million Vs 158.3385 Million expected.
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
NovoCure ($NVCR) reported EPS of -0.33 beating estimate of -0.42 for Q3 2025. Revenue 167.204 Million Vs 158.3385 Million expected.
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
October 30, 2025 at 11:07 AM
NovoCure ($NVCR) reported EPS of -0.33 beating estimate of -0.42 for Q3 2025. Revenue 167.204 Million Vs 158.3385 Million expected.
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.io
Chat with FundSpec AI to analyze your stocks and access financial data on the FundSpec App available on the AppStore or PlayStore!
No Kings in DC was great. Momentum is building for exactly the kind of NVCR movement the US needs. Quoted here. www.rollingstone.com/politics/pol...
America Is 'Worth Fighting For' Say Protesters at 'No Kings' Rally
In the largest protests against Trump's administration and policies to date, participants express fear and loathing at America’s political trajectory.
www.rollingstone.com
October 19, 2025 at 10:16 PM
No Kings in DC was great. Momentum is building for exactly the kind of NVCR movement the US needs. Quoted here. www.rollingstone.com/politics/pol...
Novocure up after Japan approves lung cancer treatment — TradingView News
https://www.byteseu.com/1381266/
** Shares of cancer therapy maker Novocure NVCR up 1.4% at $12.32 premarket ** Company says Japan’s health ministry has approved NVCR’s Optune Lua for patients with advanced or recurrent …
https://www.byteseu.com/1381266/
** Shares of cancer therapy maker Novocure NVCR up 1.4% at $12.32 premarket ** Company says Japan’s health ministry has approved NVCR’s Optune Lua for patients with advanced or recurrent …
Novocure up after Japan approves lung cancer treatment — TradingView News - Bytes Europe
** Shares of cancer therapy maker Novocure NVCR up 1.4% at $12.32 premarket
www.byteseu.com
September 15, 2025 at 12:52 PM
Novocure up after Japan approves lung cancer treatment — TradingView News
https://www.byteseu.com/1381266/
** Shares of cancer therapy maker Novocure NVCR up 1.4% at $12.32 premarket ** Company says Japan’s health ministry has approved NVCR’s Optune Lua for patients with advanced or recurrent …
https://www.byteseu.com/1381266/
** Shares of cancer therapy maker Novocure NVCR up 1.4% at $12.32 premarket ** Company says Japan’s health ministry has approved NVCR’s Optune Lua for patients with advanced or recurrent …
Follow Play Earnings CallPlay Earnings Call NovoCure Limited (NASDAQ:NVCR) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 ... Read more
https://thelegendofhanuman.in/2025/09/novocure-limited-nvcr-presents-at-morgan-stanley-23rd-annual-global-healthcare/
https://thelegendofhanuman.in/2025/09/novocure-limited-nvcr-presents-at-morgan-stanley-23rd-annual-global-healthcare/
September 10, 2025 at 10:00 PM
Follow Play Earnings CallPlay Earnings Call NovoCure Limited (NASDAQ:NVCR) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 ... Read more
https://thelegendofhanuman.in/2025/09/novocure-limited-nvcr-presents-at-morgan-stanley-23rd-annual-global-healthcare/
https://thelegendofhanuman.in/2025/09/novocure-limited-nvcr-presents-at-morgan-stanley-23rd-annual-global-healthcare/
#NVCR Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
https://www.stocktitan.net/news/NVCR/novocure-announces-coverage-of-tumor-treating-fields-tt-fields-iqx4kdviiae0.html
https://www.stocktitan.net/news/NVCR/novocure-announces-coverage-of-tumor-treating-fields-tt-fields-iqx4kdviiae0.html
Major Brain Cancer Treatment Breakthrough: Novocure's TTFields Now Covered in Spain's Health System
TTFields therapy for newly diagnosed glioblastoma patients now available through Spanish National Health System. Treatment used by 35,000+ patients globally, marks 9th country for coverage.
www.stocktitan.net
August 25, 2025 at 11:00 AM
#NVCR Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
https://www.stocktitan.net/news/NVCR/novocure-announces-coverage-of-tumor-treating-fields-tt-fields-iqx4kdviiae0.html
https://www.stocktitan.net/news/NVCR/novocure-announces-coverage-of-tumor-treating-fields-tt-fields-iqx4kdviiae0.html
#NVCR Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
https://www.stocktitan.net/news/NVCR/novocure-submits-premarket-approval-application-to-fda-for-tumor-p87qx5hculja.html
https://www.stocktitan.net/news/NVCR/novocure-submits-premarket-approval-application-to-fda-for-tumor-p87qx5hculja.html
Breakthrough Pancreatic Cancer Treatment: Novocure's TTFields Therapy Seeks FDA Approval After Success
Novocure submits PMA application for TTFields therapy in locally advanced pancreatic cancer, following successful PANOVA-3 trial. FDA decision expected H2 2026.
www.stocktitan.net
August 20, 2025 at 11:00 AM
#NVCR Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
https://www.stocktitan.net/news/NVCR/novocure-submits-premarket-approval-application-to-fda-for-tumor-p87qx5hculja.html
https://www.stocktitan.net/news/NVCR/novocure-submits-premarket-approval-application-to-fda-for-tumor-p87qx5hculja.html
MTG THROWS Trump UNDER THE BUS as he DITCHES HER
YouTube video by MeidasTouch
youtube.com
August 13, 2025 at 3:45 PM
